Advertisement

Opiant Pharmaceuticals, Inc. OPNT

Set alert

Price alert · OPNT

All alert types
20.65 +20.65 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
108.80M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-4.88
Beta
0.83
Short ratio
0.56
Inst. own
42.00%
Dividend
0.00
Ex-div date
Earnings
Mar 21, 2023
50-d avg
20.50
200-d avg
14.79
1y target
21.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for OPNT has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Operating Income → Expenses: $174.00KExpenses → Selling, General & Admin: $5.67MExpenses → Research & Development: $4.13MExpenses → Other Expenses: $174.15MGross Profit → Expenses: $173.87MRevenue → Gross Profit: $173.87MNet Loss → Expenses: $9.92MOther Operating Income$174.00KGross Profit$173.87MNet Loss$9.92MExpenses$183.97MSelling, General & Admin$5.67MResearch & Development$4.13MOther Expenses$174.15MRevenue$173.87M

Period ending Sep 30, 2022 · select a line to chart its history

Income statement

OPNT quarterly income statement
173.87K
173.87K
173.87K
9.80M
4.13M
5.67M
-9.63M
390.85K
8.55K
-9.92M
-9.92M
-9.92M
-9.92M
-1.93
-1.93
-1.93
-9.52M
-9.52M
5.14M
5.14M

Balance sheet

OPNT quarterly balance sheet
35.38M
35.38M
41.11K
38.55M
3.16M
41.95M
2.11M
16.51M
7.04M
14.41M
21.45M
-95.52M
-248.13K
20.50M
20.50M
3.40M
16.51M
10.60K
14.41M
3.11M

Cash flow

OPNT quarterly cash flow
189.44K
402.62K
-4.80M
-411.08K
402.62K
-411.08K
-4.74M
-48.76K
424.68K
Advertisement